International Liver Cancer Association 1st Annual Conference October 5 – October 6, 2007 Barcelona, Spain
Mission The International Liver Cancer Association (ILCA) aims at advancing research in the pathogenesis, prevention, and treatment of liver cancer. It promotes novel pathogenic, diagnostic and therapeutic interventions for liver cancer by taking a transversal approach to research and bringing together scientists, physicians and allied professionals from all interrelated fields.
Conference Report
Facts - State of the art sessions and symposia proposed - An outstanding panel of renowned speakers - 603 persons attended this event from 37 different countries - Multi-disciplinary and professional scope attracted clinical, translational and basic researchers, physicians and allied professionals from around the globe.
Abstracts 305 abstracts received 298 abstracts selected 30 Oral communications 17 Top-scored posters on display for two days 241 posters on display for one day
Registration Statistics Total registrations: 603 ILCA members: 176 Non member: 427 Early Registrations: 206 Late Registrations: 316 On site Registrations: 81
Registration Demographics Number of countries represented: 37 Continents Top 5 Countries Europe: 66% Spain (81) North America: 14% United States (63) Asia & Australia: 14% France (57) Africa: 3% Italy (47) South America: 2% Germany (44)
Sponsors
Main Sponsors Platinum Sponsor Silver Sponsors Symposium Sponsor
Other Sponsors Cisbio International. (advertisment) Covidien frm Other Sponsors Cisbio International (advertisment) Covidien frm. Tyco Healthcare (stand) Eisai (grant) National Institutes of Health (grant) Philips (stand) Raptor Pharma (grant) Sirtex (internet café & stand)